AKT1 and neoplasm: Pitavastatin significantly enhances the efficacy of cisplatin in lung cancer cells and its tumor xenograft model without causing toxicity in mice; this effect is mediated by the suppression of Ras/Raf/MEK and PI3K/Akt/mTOR signaling [139].